Navigation Links
Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery
Date:7/11/2014

Scottsdale, AZ (PRWEB) July 11, 2014

Cayenne Medical, Inc., a privately held sports medicine device company specializing in the soft tissue reconstruction segment, announced the worldwide launch of the SureLock All-Suture Anchor System for surgeries involving the shoulder and extremities. The SureLock System provides strong, predictable fixation through a novel, inserter-controlled deployment method. The unique delivery eliminates manual tensioning that can lead to partial deployment, anchor pull-out, or anchor displacement (also commonly know as anchor “creep”). SureLock keeps the creep out of all-suture anchor fixation by consistently deploying the anchor beneath the cortex. The SureLock System will be on display for demonstration during the 2014 American Orthopaedic Society for Sports Medicine Annual Meeting (AOSSM), July 10-12, Seattle, Washington at booth # 313.

“Cayenne Medical has seen great clinical success with the SureLock All-Suture Anchor System since its limited market release earlier this year, and we are excited to announce a full market launch which allows us to open up domestic and international markets,” said Dave Springer, President and CEO of Cayenne Medical. “We are delighted that many surgeons have embraced the reliable technology of our innovative all-suture anchor, which builds upon our best-in-class soft tissue repair solutions for the knee, shoulder and extremities.”

The SureLock All-Suture Anchor is composed of Ultra High Molecular Weight Polyethylene (UHMWPE) suture and is available in 1.4mm (single loaded) and 2.2mm (double loaded) sizes. SureLock requires a smaller pilot hole compared to traditional anchors, minimizing bone removal and decreasing the overall anchor footprint, while still providing superior strength. The SureLock delivery system is designed to provide a consistent, reproducible technique to eliminate the inconsistency seen with other all-suture anchors on the market.

"The SureLock Anchor provides excellent stability immediately upon deployment without the worry of anchor creep commonly seen with other all-suture anchors,” states Andrew Willis, MD, of Tri-County Orthopedics, Morristown, New Jersey. “This superior product delivers the reliability and strength of a traditional suture anchor, yet has the advantages of an all-suture anchor construct. The SureLock System is the next generation of all-suture anchor fixation because it brings you the best of both worlds."

About Cayenne Medical, Inc.
Cayenne Medical designs, develops and markets technically advanced soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005, the company is leading the transformation of traditional arthroscopic procedures by applying innovative technology through minimally invasive techniques.

Cayenne Medical Product Lines
The complete sports medicine offering of knee products includes: AperFix® ,the only soft tissue multi-ligament system with rigid aperture fixation, CrossFix®, an all-suture meniscal repair device, and iFix®, for bone-tendon-bone fixation. Cayenne Medical also offers the Quattro System®, a complete line of shoulder products for rotator cuff repair, labral repair, and beyond. The company recently expanded its product portfolio to include the Mirror™ Partial Knee System, incorporating proprietary technology that uniquely tensions the ligaments to balance the knee throughout the entire range of motion.

For more information, please visit http://www.cayennemedical.com.

###
Cayenne Medical, AperFix, CrossFix, iFix and Quattro are registered trademarks of Cayenne Medical, Inc.

SureLock and Mirror are trademarks of Cayenne Medical, Inc.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12011146.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
2. DiaTech Life Sciences Announces Medical Advisory Board
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
6. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):